Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The combination treatment didn't work better than minoxidil alone and caused more menstrual issues.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Higher SFRP-4 levels were found in people without a diabetic family history.

Weight loss can lower AMH levels in overweight and obese women with PCOS.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

An unhealthy lifestyle increases the risk of metabolic syndrome.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Raltegravir may cause hair loss in some patients.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Generic Palbociclib is safe and tolerable for treating certain breast cancer types.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Some people have a genetic variation that makes them less effective at breaking down drugs.